Prostate Cancer: Clinical Study Shows Superior Efficacy of Docetaxel Chemotherapy - The chemotherapy drug docetaxel currently offers the best treatment for androgen-independent prostate cancer. That is the result of a now published clinical trial that compared the efficacy of the two most widely used chemotherapy drugs. When using docetaxel, the risk of disease progression was cut by more than 50% than when using the next-best chemotherapy drug. The use of chemotherapy to treat prostate cancer has rapidly grown in importance over recent years, with several comprehensive clinical trials helping to drive forward progress. In two of these trials, the chemotherapy drug docetaxel offered patients a significantly improved prognosis.
International Press Release Publishing for free in 15 languages across 22 countries
Press Releases
Google-Suche:
 

Blog blogger.com

You are not logged in, so we don't know your blog. Please fill in the data to access your blog at blogger.com. The entered information will be stored for this session.
Username
Password
Blog-URL
 
Title of your post
Text of your post
SUBCATEGORIES
Medicine
 
 
Pressreleases by authors
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z